Form 8-K - Current report:
SEC Accession No. 0001558370-22-014884
Filing Date
2022-10-06
Accepted
2022-10-06 16:40:51
Documents
12
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K omer-20220930x8k.htm   iXBRL 8-K 40753
  Complete submission text file 0001558370-22-014884.txt   159116

Data Files

Seq Description Document Type Size
2 EX-101.SCH omer-20220930.xsd EX-101.SCH 3265
3 EX-101.LAB omer-20220930_lab.xml EX-101.LAB 15361
4 EX-101.PRE omer-20220930_pre.xml EX-101.PRE 10392
6 EXTRACTED XBRL INSTANCE DOCUMENT omer-20220930x8k_htm.xml XML 4664
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 221298522
SIC: 2834 Pharmaceutical Preparations